Vaxfab Enterprises Ltd

Vaxfab Enterprises Ltd. has issued a clarification regarding its 43rd Annual General Meeting (AGM), which will be held on Tuesday, September 29, 2026, at 12:00 noon IST. The meeting will take place at the company's registered office in Ahmedabad, Gujarat. Key agenda items include the adoption of the Audited Standalone and Consolidated Financial Statements for the fiscal year ended March 31, 2026, the reappointment of Mr. Ravindra Ashokbhai Joshi as Managing Director, and the appointment of M/s. Chandabhoy & Jassoobhoy as Statutory Auditors for a five-year term with a proposed remuneration of ₹3,00,000 for FY 2026-27. Additionally, the company plans to seek shareholder approval to increase its authorized share capital from ₹35 crore to ₹50 crore.

Vaxfab Enterprises Ltd has announced its 43rd Annual General Meeting (AGM) will be held on Tuesday, September 29, 2026, at 12:00 noon IST at the company's registered office in Ahmedabad. The meeting agenda includes the adoption of the Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2026, the re-appointment of Mr. Ravindra Ashokbhai Joshi as Managing Director, and the appointment of M/s. Chandabhoy & Jassoobhoy as Statutory Auditors for a term of five years with a proposed remuneration of ₹3,00,000 for FY 2026-27. Additionally, shareholders will vote on a special business item to increase the authorized share capital from ₹35 crore to ₹50 crore and alter the Memorandum of Association.

Vaxfab Enterprises Limited has announced its Annual General Meeting (AGM) for the Financial Year 2025-26. The AGM is scheduled for Tuesday, 29th September, 2026, at 12:00 Noon, to be held at the company's registered office in Ahmedabad. Key agenda items include the adoption of the Audited Standalone and Consolidated Financial Statements for FY 2025-26, the re-appointment of Mr. Ravindra Ashokbhai Joshi as Managing Director, and the appointment of M/s. Chandabhoy & Jassoobhoy as Statutory Auditors for a term of five years. The notice of the AGM and related documents have been made available on the company's website.

Vaxfab Enterprises Limited has announced its 43rd Annual General Meeting (AGM) will be held on Tuesday, September 29, 2026, at 12:00 Noon at its registered office in Ahmedabad. The meeting will include the adoption of audited standalone and consolidated financial statements for FY 2025-26, the reappointment of Mr. Ravindra Ashokbhai Joshi as Managing Director, and the appointment of M/s. Chandabhoy & Jassoobhoy as Statutory Auditors for a five-year term with proposed remuneration of Rs. 3,00,000 for FY 2026-27.

Vaxfab Enterprises Ltd announced that its Board of Directors, in a meeting held on September 7, 2026, approved an increase in the company's authorized share capital from ₹35 crore to ₹50 crore. This increase will be divided into 4,97,00,000 Equity Shares of ₹10 each and 3,00,000 Preference Shares of ₹10 each. The Board also approved the Draft Directors' Report for the financial year ended March 31, 2026, and announced that the 43rd Annual General Meeting (AGM) will be held on September 29, 2026. The company will provide remote e-voting facilities to its members from September 26 to September 28, 2026. Mrs. Shubhangi Rajkumar Agarwal has been appointed as the scrutinizer for the AGM.

Vaxfab Enterprises Ltd announced the allotment of 8,26,761 equity shares, each with a face value of ₹10, at a price of ₹21.02 per share. This allotment is a result of the conversion of warrants into fully paid-up equity shares on a preferential basis. The conversion has increased the company's paid-up equity share capital to ₹25,82,64,060, comprising 2,58,26,406 equity shares. The newly allotted shares will rank pari-passu with the existing equity shares. The Board of Directors approved this allotment during their meeting held on August 17, 2026.

Vaxfab Enterprises Ltd announced the allotment of 8,26,761 equity shares following the conversion of warrants. The shares were issued at a price of ₹21.02 each, fully paid up, on a preferential basis to nine investors. This allotment increases the company's paid-up equity share capital to ₹25,82,64,060, comprising 2,58,26,406 equity shares. The newly allotted shares will rank pari-passu with existing equity shares.

Vaxfab Enterprises Ltd announced that its Board of Directors, in a meeting held on August 14, 2026, approved the unaudited financial results for the quarter ended June 30, 2026. The results were accompanied by a Limited Review Report from the statutory auditor. The board meeting commenced at 7:00 p.m. and concluded at 7:30 p.m. The auditor's report included a qualified opinion due to issues with prior period records and documentation, impacting the completeness, accuracy, and recoverability of certain balances and transactions.

Vaxfab Enterprises Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved the results in a meeting held on August 14, 2026. The financial statements were accompanied by a Limited Review Report from the statutory auditor. The auditor's report was qualified due to issues with record-keeping and documentation from previous management, impacting the completeness, accuracy, and recoverability of related balances and transactions. The review was conducted in accordance with SRE 2410, providing limited assurance.

Vaxfab Enterprises Ltd has announced the incorporation of its wholly owned subsidiary, Al Rafa Enterprise FZ-LLC, in the United Arab Emirates (UAE). The subsidiary, established on August 6, 2026, will engage in Seeds Trading, Packing & Packaging Materials Trading, Plastic & Nylon Raw Materials Trading, Information Technology Consultants, and General Trading. The initial capital will be in cash, with a proposed initial capital of AED 1,000.00 per share. The company cited a delay in filing due to the late receipt of legal documents. This move signifies Vaxfab's international expansion strategy.